
Micronesia’s first outbreak of COVID-19 has grown in one week to over 1,000 cases, causing significant alarm in the Pacific …

New NICE guidance has been released, recommending the routine use of placental growth factor (PIGF), based on testing in the …

Global Blood Therapeutics (GBT) has announced the MHRA marketing authorisation for Oxbryta® (voxelotor) for the treatment of haemolytic anaemia due …

HealthTrackRx is now offering a molecular test for detection of the human monkeypox virus. The test was developed by the …

New modelling research carried out by the Institute of Alcohol Studies (IAS) and Health Lumen, has found that if alcohol …

AstraZeneca’s Tezspire (tezepelumab) has been recommended for marketing authorisation in the EU, as an add-on therapy in patients 12 years …
VistaGen Therapeutics has announced topline data from its Phase III PALISADE-1 trial which shows that PH94B, its nasal spray candidate …

Recent acute hepatitis cases of unknown origin in children have now been linked to the virus AAV2 in two new …

For the second time in two years, WHO declared a global health emergency, this time for monkeypox. The declaration is …
A recent report by MPs say that the large number of unfilled NHS job vacancies is posing a serious risk …

Abemaciclib (Verzenios) has been approved by the NICE to treat some people with breast cancer that has a high-risk of …
The CMA has found that Pfizer and Flynn charged unfairly high prices for phenytoin sodium capsules for over four years, …

The CHMP has adopted a positive opinion relating to the use of Lupkynis (voclosporin) in combination with mycophenolate mofetil for …

Cancer Research UK and Sosei Heptares have announced the signing of an agreement to bring Sosei Heptares’ cancer immunotherapy drug …

Scientists in the UK think they have understood the mechanism behind junk DNA, which is implicated in cancer. Junk DNA …

AbbVie and iSTAR Medical SA have announced a strategic transaction to further develop and commercialise iSTAR Medical’s MINIject® device. The …

The European Commission (EC) has granted a marketing authorisation for Upstaza™ (eladocagene exuparvovec), the world’s first disease-modifying treatment for aromatic …

Researchers have found that a single injection of a new gene therapy, called FLT180a, removed the need for people to …

A major review has found “no clear evidence” that low serotonin levels are responsible for depression. Reviewing existing studies, researchers …
All those aged 50 and over will be offered a COVID-19 booster vaccine this autumn, to top up their immunity …